Ecap Capital Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Ecap Capital

Access the complete profile.

Ecap Capital Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	52311 Investment Banking & Securities Dealing
Address	40 Deer Park Road First Floor Katonah, NY 10536

Note: Revenues for privately held companies are statistical evaluations.


Ecap Capital's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Ecap Capital's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Ecap Capital is classified as operating in the Investment Banking & Securities Dealing industry, NAICS Code 52311.

Ecap Capital Annual Revenue and Growth Rate

Ecap Capital	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Ecap Capital's revenues are gauged from an analysis of company filings.

Ecap Capital's Income Statement (based on Industry Averages)

Ecap Capital P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Ecap Capital is developing and marketing. Ecap Capital doesn't have any recent trademark applications, indicating Ecap Capital is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
EAT. SPRAY. LOVE. Edible oils	08/25/2014
THERA MAX Homeopathic pharmaceuticals for use in the treatment of headaches; homeopathic pharmaceuticals for use in the treatment of allergies; homeopathic pharmaceuticals for use in the treatment of colds; homeopathic pharmaceuticals for use in the treatment of colds and flu; herbal supplements; and natural herbal supplements for immune system support	11/03/2008

See all trademarks and details in the Full Report.

Market Share of Ecap Capital's Largest Competitors

A competitive analysis shows these companies are in the same general field as Ecap Capital, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
GOLDMAN SACHS ASSET MANAGEMENT	New York, NY	100
RAYMOND JAMES INVESTMENT MANAGEMENT	St Petersburg, FL	39
MERRILL LYNCH	New York, NY	19
SAFE HARBOR PUBLICATIONS	Southampton, NY	17
STIFEL FINANCIAL	St Louis, MO	16
CREDIT SUISSE ASSET MANAGEMENT	New York, NY	12
RBC CAPITAL MARKETS	New York, NY	8
BNP PARIBAS ASSET MANAGEMENT USA	New York, NY	7
MACQUARIE HOLDINGS USA	New York, NY	7

Nearby Competitors

These companies are similar in business line and location to Ecap Capital. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
OTA MANAGEMENT	Purchase, NY	100
BELLE HAVEN INVESTMENTS	Rye Brook, NY	90
PASTERNAK BAUM	Harrison, NY	48
VERTICAL GROUP	Rye, NY	43
TRUMAN CAPITAL ADVISORS	Armonk, NY	37
CHEMLUBE INTERNATIONAL	Harrison, NY	35

Other Companies at 40 Deer Park Road, Katonah NY

Company	Headquarters	Revenue ($ MM)
SEMMENS ASSOCIATES P.C.	Katonah, NY	100
SJ AUTO TRADE	Katonah, NY	0
MODESO	Katonah, NY	0

Future Competition: Ecap Capital's Fastest Growing Competitors

These companies are in the same general field as Ecap Capital and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)